Alternatives to Edesa Biotech, .
Edesa Biotech, . is a Biotech tool: edesa Biotech is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Edesa Biotech, .
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
VISEN Pharmaceuticals43BiotechSan Diego, United States$200.0MVISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.
- Website
Ferring Pharmaceuticals36BiotechSaint-Prex, Switzerland$570.0MA global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Amicus Therapeutics57BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Cellcolabs55BiotechTel Aviv, Israel$15.5MAI-powered platform for personalized cell therapy development and manufacturing.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Ultragenyx55BiotechNovato, United States$100.0MBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
Regenxbio55BiotechRockville, United States$180.0MClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Sylentis55BiotechMadrid, Spain$135.0MOphthalmic pharmaceutical company developing novel treatments for ocular diseases.
- Website
ProteinQure54BiotechCambridge, United States$15.6MBiotech company using AI and computational platforms to design novel peptide therapeutics.
Showing the 20 closest matches. See the rest on the Edesa Biotech, . profile.
Compare Edesa Biotech, . head to head
Side by side on what each one does, what it costs, and what real users report.